Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)

Funding Opportunity RFA-HL-21-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks both applications from established sites of the Sickle Pan-African Research Consortium (SPARCO) and applications from other Sub-Saharan African nations to become the Consortiums new sites. The renewed and expanded SPARCO including a Clinical Coordinating Center (CCC), up to 3 established sites and additional satellite sites, up to 3 new sites, and the associated Sickle Africa Data Coordinating Center (SADaCC) will together constitute the Sickle Cell Disease (SCD) in Sub-Saharan Africa (SSA) Network. This network aims at developing a sustainable resource that will advance SCD-related epidemiologic, translational, and clinical studies.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding